SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001654954-20-008045
Filing Date
2020-07-27
Accepted
2020-07-27 17:27:22
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-3 azrxs3_july272020.htm S-3 1039544
2 EXHIBIT 4.2 ex4-2.htm EX-4.2 65064
3 EXHIBIT 5.1 ex5-1.htm EX-5 17326
4 EXHIBIT 23.2 ex23-2.htm EX-23 4052
5 IMAGE azrxs3_july272020000.jpg GRAPHIC 2869
6 IMAGE azrxs3_july272020001.jpg GRAPHIC 3831
7 IMAGE ex5-1000.jpg GRAPHIC 6896
8 IMAGE lowensteinsandler.jpg GRAPHIC 12267
  Complete submission text file 0001654954-20-008045.txt   1157875
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-240129 | Film No.: 201051191
SIC: 2834 Pharmaceutical Preparations